| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69097-917-02 | 69097-917 | HUMAN PRESCRIPTION DRUG | bupropion Hydrochloride | bupropion Hydrochloride | TABLET | ORAL | 20180526 | N/A | ANDA | ANDA207389 | CIPLA USA INC., | BUPROPION HYDROCHLORIDE | 75 mg/1 | 30 TABLET in 1 BOTTLE (69097-917-02) |
| 69097-917-07 | 69097-917 | HUMAN PRESCRIPTION DRUG | bupropion Hydrochloride | bupropion Hydrochloride | TABLET | ORAL | 20180526 | N/A | ANDA | ANDA207389 | CIPLA USA INC., | BUPROPION HYDROCHLORIDE | 75 mg/1 | 100 TABLET in 1 BOTTLE (69097-917-07) |
| 69097-917-15 | 69097-917 | HUMAN PRESCRIPTION DRUG | bupropion Hydrochloride | bupropion Hydrochloride | TABLET | ORAL | 20180526 | N/A | ANDA | ANDA207389 | CIPLA USA INC., | BUPROPION HYDROCHLORIDE | 75 mg/1 | 1000 TABLET in 1 BOTTLE (69097-917-15) |
| 69097-918-02 | 69097-918 | HUMAN PRESCRIPTION DRUG | bupropion Hydrochloride | bupropion Hydrochloride | TABLET | ORAL | 20180526 | N/A | ANDA | ANDA207389 | CIPLA USA INC., | BUPROPION HYDROCHLORIDE | 100 mg/1 | 30 TABLET in 1 BOTTLE (69097-918-02) |
| 69097-918-07 | 69097-918 | HUMAN PRESCRIPTION DRUG | bupropion Hydrochloride | bupropion Hydrochloride | TABLET | ORAL | 20180526 | N/A | ANDA | ANDA207389 | CIPLA USA INC., | BUPROPION HYDROCHLORIDE | 100 mg/1 | 100 TABLET in 1 BOTTLE (69097-918-07) |
| 69097-918-15 | 69097-918 | HUMAN PRESCRIPTION DRUG | bupropion Hydrochloride | bupropion Hydrochloride | TABLET | ORAL | 20180526 | N/A | ANDA | ANDA207389 | CIPLA USA INC., | BUPROPION HYDROCHLORIDE | 100 mg/1 | 1000 TABLET in 1 BOTTLE (69097-918-15) |